Imaging and pathological features of primary hepatic neuroendocrine carcinoma: An analysis of nine cases and review of the literature

Chen,Zhu; Xiao,Hua‑En; Ramchandra,Paudel; Huang,Hai‑Jiang

doi:10.3892/ol.2014.1844

Imaging and pathological features of primary hepatic neuroendocrine carcinoma: An analysis of nine cases and review of the literature

Authors:
- Zhu Chen
- Hua‑En Xiao
- Paudel Ramchandra
- Hai‑Jiang Huang
View Affiliations

Affiliations: Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China, Department of Pathology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China
Published online on: January 31, 2014 https://doi.org/10.3892/ol.2014.1844
Pages: 956-962

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to analyze the imaging features and pathological basis of primary hepatic neuroendocrine carcinoma (PHNEC). A retrospective analysis of the imaging and pathological features of nine PHNEC cases was carried out at The Second Xiangya Hospital of Central South University (Changsha, China). The nine patients were subjected to dynamic contrast‑enhanced computed tomography (CT) scanning of the liver and pathological diagnosis of the tissue samples. In addition, two patients were subjected to magnetic resonance imaging (MRI). CT scanning revealed the presence of single or multiple masses in the liver with a maximum diameter of 1‑10 cm. These hepatic masses were of low density as showed by plain CT. These masses showed uneven or annular enhancement at their margins in the arterial phase. The venous portal phase showed consistent or declined enhancement and the delayed phase showed light enhancement in these masses. In addition, multiple intrahepatic nodules with long T1 and T2 signal intensities and obvious enhancement were observed by MRI in one patient, while intrahepatic lesions with moderate length T2 signal intensities and light enhancement not visible on the T1 image were observed in another patient. Pathological analysis revealed that the tumor cells exhibited morphological diversity. Immunohistochemical staining revealed that the tumor cells were chromogranin A‑ and synaptophysin‑positive, and carcinoembryonic antigen‑, hepatocytic antigen‑ and α‑fetoprotein‑negative. Imaging methods, including CT and MRI, are useful for the diagnosis of PHNEC; however, pathological examination is required for a final, definite diagnosis.

View Figures

View References

1	Dogra VS and Poblete J: Metastatic carcinoid tumor in the liver. J Clin Ultrasound. 21:639–641. 1993. View Article : Google Scholar : PubMed/NCBI
2	Newton JN, Swerdlow AJ, dos Santos Silva IM, Vessey MP, Grahame-Smith DG, Primatesta P and Reynolds DJ: The epidemiology of carcinoid tumors in England and Scotland. Br J Cancer. 70:939–942. 1994. View Article : Google Scholar : PubMed/NCBI
3	Yalav O, Ülkü A, Akçam TA, Demiryürek H and Doran F: Primary hepatic neuroendocrine tumor: five cases with different preoperative diagnoses. Turk J Gastroenterol. 23:272–278. 2012.PubMed/NCBI
4	Shetty PK, Baliqa SV, Balaiah K and Gnana PS: Primary hepatic neuroendocrine tumor: an unusual cystic presentation. Indian J Pathol Microbiol. 53:760–762. 2010. View Article : Google Scholar : PubMed/NCBI
5	Ishida M, Seki K, Tatsuzawa A, et al: Primary hepatic neuroendocrine carcinoma coexisting with hepatocellular carcinoma in hepatitis C liver cirrhosis: report of a case. Surg Today. 33:214–218. 2003. View Article : Google Scholar : PubMed/NCBI
6	Zheng W, Hua H and Shi W: Primary hepatic neuroendocrine carcinoma: report of 2 cases. J Pract Oncol. 25:459–460. 2010.
7	Gravante G, De Liguori Carino N, Overton J, Manzia TM and Orlando G: Primary carcinoids of the liver: a review of symptoms, diagnosis and treatments. Dig Surg. 25:364–368. 2008. View Article : Google Scholar : PubMed/NCBI
8	Endo S, Dousei T, Yoshikawa Y, et al: Gastric neuroendocrine tumors in our institutions according to the WHO 2010 classification. Int Surg. 97:335–339. 2012. View Article : Google Scholar : PubMed/NCBI
9	Sundin A, Eriksson B, Bergström M, Långström B, Oberg K and Orlefors H: PET in the diagnosis of neuroendocrine tumors. Ann NY Acad Sci. 1014:246–257. 2004. View Article : Google Scholar : PubMed/NCBI
10	Campana D, Nori F, Piscitelli L, Morselli-Labate AM, Pezzilli R, Corinaldesi R and Tomassetti P: Chromogranin A: is it a useful marker of neuroendocrine tumors? J Clin Oncol. 25:1967–1973. 2007. View Article : Google Scholar : PubMed/NCBI
11	Pilichowska M, Kimura N, Ouchi A, et al: Primary hepatic carcinoid and neuroendocrine carcinoma: clinicopathological and immunohistochemical study of five cases. Pathol Int. 49:318–324. 1999. View Article : Google Scholar
12	Sano K, Kosuge T, Yamamoto J, Shimada K, Takayama T, Yamasaki S and Makuuchi M: Primary hepatic carcinoid tumors confirmed with long-term follow-up after resection. Hepatogastroenterology. 46:2547–2550. 1999.PubMed/NCBI
13	van der Hoef M, Crook DW, Marincek B and Weishaupt D: Primary neuroendocrine tumors of the liver: MRI features in two cases. Abdom Imaging. 29:77–81. 2004.PubMed/NCBI
14	Kong W, Qiu Y, Zhang W, Jun C, Zhu X, Qiu J and Ding Y: Diagnosis of primary hepatic carcinoid tumor: report of one case. Chinese-German J Clin Oncol. 7:673–675. 2008. View Article : Google Scholar
15	Kumbasar B, Kamel IR, Tekes A, Eng J, Fishman EK and Wahl RL: Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS. Abdom Imaging. 29:696–702. 2004. View Article : Google Scholar : PubMed/NCBI
16	Schwartz G, Colanta A, Gaetz H, Olichney J and Attiyeh F: Primary carcinoid tumors of the liver. World J Surg Oncol. 6:912008. View Article : Google Scholar : PubMed/NCBI
17	Fenoglio LM, Severini S, Ferrigno D, et al: Primary hepatic carcinoid: a case report and literature review. World J Gastroenterol. 15:2418–2422. 2009. View Article : Google Scholar : PubMed/NCBI
18	Zhu Z, Zhao X and Zhou C: Imaging features of primary hepatic endocrine carcinoma. Zhongguo Yi Xue Ying Xiang Ji Shu. 4:721–723. 2010.(In Chinese).
19	Ren Y, Wang S, Chen J and Li Y: Primary hepatic neuroendocrine carcinoma: report of 4 cases. Radiol Practice. 26:687–688. 2011.
20	Takayasu K, Muramatsu Y, Sakamoto M, et al: Findings in primary hepatic carcinoid tumor: US, CT, MRI, and angiography. J Comput Assist Tomogr. 16:99–102. 1992. View Article : Google Scholar : PubMed/NCBI
21	Touloumis Z, Delis SG, Triantopoulou C, Giannakou N, Avgerinos C and Dervenis C: Primary hepatic carcinoid; a diagnostic dilemma: a case report. Cases J. 1:3142008. View Article : Google Scholar : PubMed/NCBI
22	Mazzaglia PJ, Berber E, Milas M and Siperstein AE: Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival. Surgery. 142:10–19. 2007.
23	Fewick SW, Wyatt JI, Toogood GJ and Lodqe JP: Hepatic resection and transplantation for primary carcinoid tumors of the liver. Ann Surg. 239:210–219. 2004. View Article : Google Scholar : PubMed/NCBI
24	Gurung A, Yoshida EM, Scudamore CH, Hashim A, Erb SR and Webber DL: Primary hepatic neuroendocrine tumor requiring live donor liver transplantation: case report and concise review. Ann Hepatol. 11:715–720. 2012.
25	Modlin IM, Kidd M, Latich I, Zikusoka MN and Shapiro MD: Current status of gastrointestinal carcinoids. Gastroenterology. 128:1717–1751. 2005. View Article : Google Scholar : PubMed/NCBI
26	Iwao M, Nakamuta M, Enjoji M, et al: Primary hepatic carcinoid tumor: case report and review of 53 cases. Med Sci Monit. 7:746–750. 2001.PubMed/NCBI